AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE APPLICATION OF NASAL EPINEPHRINE.
Signed
Email me when HB 466 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 466. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill lets colleges keep epinephrine autoinjectors and nasal sprays on site, lets trained staff give them to anyone showing anaphylaxis, and shields prescribers, pharmacists, schools and responders from most legal liability. It also requires training, certification, incident reporting and an annual state report.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 466
3 free questions a day, no accountHearings
- Senate Health & Social ServicesHealth & Social Services · Jun 24, 2026
- House Health & Human DevelopmentHealth & Human Development · Jun 9, 2026
History
- Introduced and Assigned to Health & Human Development Committee in House
Sponsors
- DeShanna Neal (D) · sponsor
- David P. Sokola
- DeShanna U Neal
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 466 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 466 freeOr ask your AI assistant about HB 466 directly:
Add to Claude, ChatGPT or Cursor